These three get discussed as if they’re variations on the same thing — they’re not. Different molecule classes, different mechanisms, different regulatory histories. Here’s the actual breakdown.
Want something built around your specific situation, not general reading? PeptideReport.ai turns a short guided intake into a free, personalized educational report you can actually bring to your doctor — and registering gets you The Peptide Bridge audiobook free, a $29.99 value, delivered to your inbox right away.
Get my free report + free book →| Peptides | SARMs | Anabolic steroids | |
|---|---|---|---|
| What they are | Short chains of amino acids that act as signaling molecules | Selective androgen receptor modulators — small synthetic molecules, not amino-acid chains | Synthetic derivatives of testosterone |
| Mechanism | Varies widely by compound — receptor binding, hormone-axis signaling, tissue-level effects (see our compounds page for specifics) | Bind to androgen receptors selectively in muscle and bone tissue, designed to minimize effects in other tissues | Bind broadly to androgen receptors throughout the body, mimicking testosterone’s full range of effects |
| Regulatory status | Ranges from FDA-approved (semaglutide) to research-use-only, compound by compound | Not FDA-approved for human use in any form; sold as "research chemicals," a legally similar gray zone to RUO peptides | Schedule III controlled substances in the US; legal only via prescription for specific medical conditions (e.g., hypogonadism) |
| Why they get grouped together | All three show up in fitness/performance and longevity forums as tools people research for body composition or recovery goals, which is a use-case grouping, not a chemical or regulatory one. | ||
Peptides are a structural category (amino acid chains) that includes compounds with completely different mechanisms from each other — there's no single "how peptides work" answer, which is part of why comparing "peptides" as a whole to SARMs or steroids is a little bit apples-to-oranges from the start. SARMs and steroids are more mechanistically similar to each other than either is to peptides generally: both work through the androgen receptor, with SARMs designed to be more tissue-selective. A peptide like BPC-157 or CJC-1295 doesn't touch the androgen receptor at all — it's working through an entirely different signaling system.
This is where the three categories diverge most sharply. Anabolic steroids are federally controlled substances — legal only through a specific prescription for a recognized medical condition, with real legal consequences for possession or use outside that framework. SARMs occupy a research-chemical gray zone broadly similar to RUO peptides: not approved for human use, sold with research-only labeling. Peptides span the widest range of any of the three, from a fully approved prescription drug at one end to an obscure research-use-only bioregulator at the other. See our full legal-status breakdown for the peptide-specific detail.
For the peptide side of this comparison in more depth, see the compounds reference page and legal status guide. For more comparisons, see the comparisons hub.
Reading about this by name is a starting point, not a plan. PeptideReport.ai turns general reading like this into a free, personalized report you can bring to a licensed physician — the person actually qualified to weigh these considerations against your health history.
Get your free report at PeptideReport.ai →
Free bonus: register today and The Peptide Bridge audiobook — a physician-authored, plain-English guide to peptide therapy, a $29.99 value — is yours free, delivered to your inbox right away.